Valtruis (WCAS XIII VBC Holdings, LP and WCAS XIV VBC Holdings, LP)

Valtruis partners with innovative leaders whose mission is to realign the U.S. healthcare system along the principles of value-based care. The Valtruis platform brings functional expertise, access to capital and an expansive network which advance our partners’ evolution from early-stage development to industry-leading enterprises. Together, Valtruis and its partner companies aim to break through the systemic barriers in the healthcare industry to reduce costs, expand access, increase quality and improve patient experience.

Current CEO: Managing Partners – Anna Haghgooie, Karey Witty, Tracy Bahl and Mike Spadafore

Headquarters: Chicago, IL, Nashville, TN and New York, NY

Investment Year: 2021 (WCAS XIII) and 2022 (WCAS XIV)

Investments: Wellvana, InterWell Health, Wayspring, HarmonyCares, Oncology Care Partners, Instride Health, TailorCare, Mass Advantage, Honest, Evergreen, Ursa Health and Tuesday Health